# Standard Biotools Inc.: filings

LAB · Nasdaq · CIK 1162194 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lab.md) · [Financials](/companies/lab/financials.md) · [Filings](/companies/lab/filings.md) · [Insiders](/companies/lab/insiders.md)

## Reports and events: 343 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 836, 8-K 214, SC 13G/A 71, 3 49, 10-Q 47, SC 13G 37, DEFA14A 26, 144 22, SC 13D/A 22, S-8 21, 425 20, 10-K 16, DEF 14A 16, SD 13, 4/A 12, CORRESP 12, UPLOAD 12, EFFECT 10, 424B5 7, ARS 7, CT ORDER 7, 8-K/A 6, S-1/A 6, S-3 6, 10-K/A 5, 424B3 5, SC 13D 5, D 4, S-4/A 4, SCHEDULE 13G/A 4, FWP 3, S-3/A 3, SCHEDULE 13D/A 3, 3/A 2, 424B2 2, 5 2, 8-A12B 2, DEFR14A 2, S-3ASR 2, S-4 2, SCHEDULE 13G 2, SC TO-C 2, 10-Q/A 1, 15-12B 1, 25 1, 424B1 1, 8-A12B/A 1, CERTNAS 1, DEFC14A 1, NT 10-Q 1, POS AM 1, POSASR 1, PRE 14A 1, PREC14A 1, PRER14A 1, S-1 1, S-1MEF 1, S-8 POS 1, SCHEDULE 13D 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-05 | 16:16 ET | [8-K](/filings/0001140361-26-038624.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-038624 |
| 2026-09-30 | 17:27 ET | [8-K](/filings/0001140361-26-038110.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-038110 |
| 2026-08-05 | 16:10 ET | [10-Q](/filings/0001193125-26-335103.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335103 |
| 2026-08-05 | 16:10 ET | [8-K](/filings/0001193125-26-335106.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-335106 |
| 2026-07-29 | 08:15 ET | [8-K/A](/filings/0001140361-26-029964.md) | 9.01 Financial statements and exhibits | 0001140361-26-029964 |
| 2026-07-28 | 08:20 ET | [8-K](/filings/0001140361-26-029841.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-029841 |
| 2026-07-24 | 16:38 ET | [8-K](/filings/0001193125-26-316183.md) | 3.01 Delisting notice | 0001193125-26-316183 |
| 2026-06-18 | 16:30 ET | [8-K](/filings/0001193125-26-275946.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-275946 |
| 2026-06-12 | 17:35 ET | [SCHEDULE 13D](/filings/0000905148-26-002940.md) | Ownership report, active investor | 0000905148-26-002940 |
| 2026-06-09 | 17:41 ET | [SCHEDULE 13D/A](/filings/0000919574-26-003923.md) | Ownership report, active investor, amended | 0000919574-26-003923 |
| 2026-06-08 | 08:31 ET | [8-K](/filings/0001104659-26-071195.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-071195 |
| 2026-06-05 | 17:01 ET | [8-K](/filings/0001193125-26-259877.md) | 8.01 Other events | 0001193125-26-259877 |
| 2026-06-03 | 16:05 ET | [8-K](/filings/0001193125-26-255403.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-255403 |
| 2026-05-28 | 16:05 ET | [8-K](/filings/0001193125-26-245181.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-245181 |
| 2026-05-06 | 16:10 ET | [10-Q](/filings/0001193125-26-208967.md) | Quarterly report, period 2026-03-31 | 0001193125-26-208967 |
| 2026-05-05 | 16:10 ET | [8-K](/filings/0001193125-26-206395.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-206395 |
| 2026-04-27 | 16:15 ET | [DEF 14A](/filings/0001140361-26-017100.md) | Proxy statement, period 2026-06-17 | 0001140361-26-017100 |
| 2026-04-24 | 16:15 ET | [8-K](/filings/0001193125-26-177290.md) | 3.01 Delisting notice | 0001193125-26-177290 |
| 2026-03-16 | 16:05 ET | [10-K](/filings/0001193125-26-108326.md) | Annual report, period 2025-12-31 | 0001193125-26-108326 |
| 2026-02-24 | 16:15 ET | [8-K](/filings/0001193125-26-067026.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-067026 |
| 2026-02-05 | 16:38 ET | [8-K/A](/filings/0001104659-26-010965.md) | 9.01 Financial statements and exhibits | 0001104659-26-010965 |
| 2026-01-30 | 09:18 ET | [8-K](/filings/0001104659-26-008375.md) | 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-008375 |
| 2026-01-08 | 07:10 ET | [8-K](/filings/0001193125-26-006996.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-006996 |
| 2025-11-28 | 17:33 ET | [SCHEDULE 13D/A](/filings/0000919574-25-007210.md) | Ownership report, active investor, amended | 0000919574-25-007210 |
| 2025-11-04 | 16:11 ET | [10-Q](/filings/0001193125-25-264695.md) | Quarterly report, period 2025-09-30 | 0001193125-25-264695 |
| 2025-11-04 | 16:10 ET | [8-K](/filings/0001193125-25-264693.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-264693 |
| 2025-09-17 | 16:05 ET | [8-K](/filings/0001193125-25-206150.md) | 2.05 Exit or disposal costs | 0001193125-25-206150 |
| 2025-09-03 | 06:05 ET | [8-K](/filings/0000950170-25-112662.md) | 2.05 Exit or disposal costs | 0000950170-25-112662 |
| 2025-08-15 | 16:05 ET | [10-Q](/filings/0000950170-25-109388.md) | Quarterly report, period 2025-06-30 | 0000950170-25-109388 |
| 2025-08-11 | 17:00 ET | [8-K](/filings/0000950170-25-106636.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-106636 |
| 2025-08-01 | 16:20 ET | [8-K](/filings/0000950170-25-101439.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-101439 |
| 2025-06-23 | 09:11 ET | [8-K](/filings/0001104659-25-061438.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-061438 |
| 2025-06-20 | 16:16 ET | [8-K](/filings/0000950170-25-088519.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-088519 |
| 2025-05-06 | 17:05 ET | [10-Q](/filings/0000950170-25-064606.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064606 |
| 2025-05-06 | 16:05 ET | [8-K](/filings/0000950170-25-064439.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-064439 |
| 2025-04-30 | 07:21 ET | [DEF 14A](/filings/0001140361-25-016515.md) | Proxy statement, period 2025-06-18 | 0001140361-25-016515 |
| 2025-03-11 | 18:20 ET | [10-K](/filings/0000950170-25-036608.md) | Annual report, period 2024-12-31 | 0000950170-25-036608 |
| 2025-03-04 | 19:46 ET | [SCHEDULE 13D/A](/filings/0000919574-25-001773.md) | Ownership report, active investor, amended | 0000919574-25-001773 |
| 2025-02-26 | 16:05 ET | [8-K](/filings/0000950170-25-027712.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-027712 |
| 2025-01-13 | 07:08 ET | [8-K](/filings/0001104659-25-002848.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-002848 |
| 2025-01-10 | 16:09 ET | [8-K](/filings/0000950170-25-004155.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-004155 |
| 2024-12-20 | 16:14 ET | [8-K](/filings/0000950170-24-139051.md) | 9.01 Financial statements and exhibits | 0000950170-24-139051 |
| 2024-11-07 | 08:06 ET | [8-K](/filings/0000950170-24-122823.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-122823 |
| 2024-11-06 | 17:17 ET | [10-Q](/filings/0000950170-24-122473.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122473 |
| 2024-10-30 | 16:17 ET | [8-K](/filings/0000950170-24-119014.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-119014 |
| 2024-09-05 | 16:07 ET | [8-K](/filings/0001104659-24-097368.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-097368 |
| 2024-08-30 | 16:08 ET | [8-K](/filings/0001104659-24-095596.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-095596 |
| 2024-08-14 | 20:54 ET | [SC 13D/A](/filings/0000919574-24-004765.md) | Ownership report, active investor, amended | 0000919574-24-004765 |
| 2024-08-06 | 16:30 ET | [10-Q](/filings/0000950170-24-091888.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091888 |
| 2024-07-31 | 16:20 ET | [8-K](/filings/0001104659-24-084362.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-084362 |

Page 1 of 7. [Older](/companies/lab/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:03 ET. No prices; not investment advice.